Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
G2 Awards Recognize Diagnostics Leaders and Innovators
From - National Intelligence Report
Amidst three days of networking, workshops, panel discussions and presentations focused on the challenges and…
Genetic Testing: More Options Require More Education
From - Diagnostic Testing & Emerging Technologies
Increasing diagnostic options for providers and patients was a common theme throughout panel discussions and presentations at…
Convergence: Diagnostics are Key to Life Sciences Innovation and Health Care Service Delivery
From - Laboratory Industry Report
Attendees at G2 Intelligence's 34th annual Lab Institute were treated to a history lesson about diagnostics as well as…
Compliance Issues Permeate Discussions Throughout Lab Institute
From - G2 Compliance Advisor
During three days of presentations, compliance issues for laboratories and pathologists permeated most of the discussions. Beginning with a workshop on…
3 Things We Learned from New OIG Report on 2015’s Top 25 Lab Tests by Medicare Payment
...
Register
PAMA Update: OIG Status Report on Implementing New Medicare Fee Schedule for Part B Lab Tests
...
Register
Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry
...
Register
OIG Highlights Largest Self-Disclosure Protocol Settlement
...
Register
Zero Tolerance of Workplace Violence: From Moral Stand to Workable Policy
...
Register
OIG Surveys How CMS is Doing on PAMA Implementation
...
Register